These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 20014819)

  • 21. Synthesis and molecular modeling of some novel hexahydroindazole derivatives as potent monoamine oxidase inhibitors.
    Gökhan-Kelekçi N; Simşek OO; Ercan A; Yelekçi K; Sahin ZS; Işik S; Uçar G; Bilgin AA
    Bioorg Med Chem; 2009 Sep; 17(18):6761-72. PubMed ID: 19682910
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Homonojirimycin isomers and N-alkylated homonojirimycins: structural and conformational basis of inhibition of glycosidases.
    Asano N; Nishida M; Kato A; Kizu H; Matsui K; Shimada Y; Itoh T; Baba M; Watson AA; Nash RJ; Lilley PM; Watkin DJ; Fleet GW
    J Med Chem; 1998 Jul; 41(14):2565-71. PubMed ID: 9651160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis, structure and conformation of partially-modified retro- and retro-inverso psi[NHCH(CF3)]Gly peptides.
    Volonterio A; Bellosta S; Bravin F; Bellucci MC; Bruché L; Colombo G; Malpezzi L; Mazzini S; Meille SV; Meli M; Ramírez De Arellano C; Zanda M
    Chemistry; 2003 Sep; 9(18):4510-22. PubMed ID: 14502637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enantiotropically-related polymorphs of {4-(4-chloro-3-fluorophenyl)-2-[4-(methyloxy)phenyl]-1,3-thiazol-5-yl} acetic acid: crystal structures and multinuclear solid-state NMR.
    Vogt FG; Katrincic LM; Long ST; Mueller RL; Carlton RA; Sun YT; Johnson MN; Copley RC; Light ME
    J Pharm Sci; 2008 Nov; 97(11):4756-82. PubMed ID: 18300300
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conformational variability of chicken cystatin. Comparison of structures determined by X-ray diffraction and NMR spectroscopy.
    Engh RA; Dieckmann T; Bode W; Auerswald EA; Turk V; Huber R; Oschkinat H
    J Mol Biol; 1993 Dec; 234(4):1060-9. PubMed ID: 8263913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitative evaluation of each catalytic subsite of cathepsin B for inhibitory activity based on inhibitory activity-binding mode relationship of epoxysuccinyl inhibitors by X-ray crystal structure analyses of complexes.
    Watanabe D; Yamamoto A; Tomoo K; Matsumoto K; Murata M; Kitamura K; Ishida T
    J Mol Biol; 2006 Oct; 362(5):979-93. PubMed ID: 16950396
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery, synthesis and biological evaluation of isoquinolones as novel and highly selective JNK inhibitors (1).
    Asano Y; Kitamura S; Ohra T; Aso K; Igata H; Tamura T; Kawamoto T; Tanaka T; Sogabe S; Matsumoto S; Yamaguchi M; Kimura H; Itoh F
    Bioorg Med Chem; 2008 Apr; 16(8):4715-32. PubMed ID: 18313304
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [RuII(NO+)]3+-core complexes with 4-methyl-pyrimidine and ethyl-isonicotinate: synthesis, X-ray structure, spectroscopy, and computational and NO-release studies upon UVA irradiation.
    Tamasi G; Curci M; Berrettini F; Justice N; Sega A; Chiasserini L; Cini R
    J Inorg Biochem; 2008 Oct; 102(10):1874-84. PubMed ID: 18684509
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mono- vs. bi-metallic assembly on a bulky bis(imino)terpyridine framework: a combined experimental and theoretical study.
    Champouret YD; Maréchal JD; Dadhiwala I; Fawcett J; Palmer D; Singh K; Solan GA
    Dalton Trans; 2006 May; (19):2350-61. PubMed ID: 16688323
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantifying weak hydrogen bonding in uracil and 4-cyano-4'-ethynylbiphenyl: a combined computational and experimental investigation of NMR chemical shifts in the solid state.
    Uldry AC; Griffin JM; Yates JR; Pérez-Torralba M; María MD; Webber AL; Beaumont ML; Samoson A; Claramunt RM; Pickard CJ; Brown SP
    J Am Chem Soc; 2008 Jan; 130(3):945-54. PubMed ID: 18166050
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular structure and benzene ring deformation of three cyanobenzenes from gas-phase electron diffraction and quantum chemical calculations.
    Campanelli AR; Domenicano A; Ramondo F; Hargittai I
    J Phys Chem A; 2008 Oct; 112(43):10998-1008. PubMed ID: 18834088
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design, structure-activity relationships, X-ray crystal structure, and energetic contributions of a critical P1 pharmacophore: 3-chloroindole-7-yl-based factor Xa inhibitors.
    Shi Y; Sitkoff D; Zhang J; Klei HE; Kish K; Liu EC; Hartl KS; Seiler SM; Chang M; Huang C; Youssef S; Steinbacher TE; Schumacher WA; Grazier N; Pudzianowski A; Apedo A; Discenza L; Yanchunas J; Stein PD; Atwal KS
    J Med Chem; 2008 Dec; 51(23):7541-51. PubMed ID: 18998662
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Three-dimensional quantitative structure-activity relationship of interleukin 1-beta converting enzyme inhibitors: A comparative molecular field analysis study.
    Kulkarni SS; Kulkarni VM
    J Med Chem; 1999 Feb; 42(3):373-80. PubMed ID: 9986707
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis, spectroscopy (IR, multinuclear NMR, ESI-MS), diffraction, density functional study and in vitro antiproliferative activity of pyrazole-beta-diketone dihalotin(IV) compounds on 5 melanoma cell lines.
    Pettinari C; Caruso F; Zaffaroni N; Villa R; Marchetti F; Pettinari R; Phillips C; Tanski J; Rossi M
    J Inorg Biochem; 2006 Jan; 100(1):58-69. PubMed ID: 16313961
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conformational change of ascidiacyclamide caused by asymmetric modification for an isoleucine residue: structural analyses of [Gly], [Leu], and [Phe]ascidiacyclamides by x-ray diffraction and NMR spectroscopy.
    Doi M; Shinozaki F; In Y; Ishida T; Yamamoto D; Kamigauchi M; Sugiura M; Hamada Y; Kohda K; Shioiri T
    Biopolymers; 1999 May; 49(6):459-69. PubMed ID: 10193193
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 4-(2-Hydroxyphenyl)-2-phenyl-2,3-dihydro-1H-1,5-benzodiazepine and the 2-(2,3-dimethoxyphenyl)-, 2-(3,4-dimethoxyphenyl)- and 2-(2,5-dimethoxyphenyl)-substituted derivatives.
    Escobar CA; Donoso-Tauda O; Araya-Maturana R; Vega A
    Acta Crystallogr C; 2007 Jul; 63(Pt 7):o426-30. PubMed ID: 17609578
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Energetics and structure of hydroxynicotinic acids. Crystal structures of 2-, 4-, 6-hydroxynicotinic and 5-chloro-6-hydroxynicotinic acids.
    Santos RC; Figueira RM; Piedade MF; Diogo HP; Minas da Piedade ME
    J Phys Chem B; 2009 Oct; 113(43):14291-309. PubMed ID: 19785458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and biological evaluation of acyclic triaryl (Z)-olefins possessing a 3,5-di-tert-butyl-4-hydroxyphenyl pharmacophore: dual inhibitors of cyclooxygenases and lipoxygenases.
    Moreau A; Rao PN; Knaus EE
    Bioorg Med Chem; 2006 Aug; 14(15):5340-50. PubMed ID: 16677817
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methyl 6-deoxy-6-iodo-alpha-D-glucopyranoside: crystal structure and high-resolution NMR spectroscopy.
    Sikorski A; Tuwalska D; Matjasik B; Liberek B
    Carbohydr Res; 2009 Apr; 344(6):830-3. PubMed ID: 19268282
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validating a strategy for molecular dynamics simulations of cyclodextrin inclusion complexes through single-crystal X-ray and NMR experimental data: a case study.
    Raffaini G; Ganazzoli F; Malpezzi L; Fuganti C; Fronza G; Panzeri W; Mele A
    J Phys Chem B; 2009 Jul; 113(27):9110-22. PubMed ID: 19526998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.